☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Henlius
Henlius and Intas’ Hetronifly (Serplulimab) Receives the CHMP’s Positive Opinion to Treat Extensive-Stage SCLC
October 23, 2024
Henlius and Sermonix Partner to Develop Lasofoxifene for Breast Cancer
January 11, 2024
Henlius Announces the Acceptance of NDA Application by NMPA for Hansizhuang to Treat Esophageal cancer
December 13, 2023
Henlius Expands its Collaboration with Accord Healthcare to Launch Hansizhuang (serplulimab injection) in Europe and India for Var...
October 30, 2023
Henlius Reports the NMPA Acceptance of NDA for Hansizhuang (serplulimab) to Treat Esophageal Squamous Cell Carcinoma
September 25, 2023
Henlius Presents P-II Clinical Trial (HLX07-ESCC201) Results of HLX07 for the Treatment of Esophageal Squamous Cell Carcinoma at A...
June 8, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.